Common Stock, Value, Issued of REVIVA PHARMACEUTICALS HOLDINGS, INC. from 31 Aug 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
REVIVA PHARMACEUTICALS HOLDINGS, INC. quarterly Common Stock, Value, Issued in USD history and change rate from 31 Aug 2018 to 30 Sep 2025.
  • REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, Value, Issued for the quarter ending 30 Sep 2025 was $9,618, a 188% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Change (%)

REVIVA PHARMACEUTICALS HOLDINGS, INC. Quarterly Common Stock, Value, Issued (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $9,618 +$6,274 +188% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $6,800 +$3,818 +128% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $4,674 +$1,882 +67% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $4,658 +$1,866 +67% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $3,344 +$1,079 +48% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $2,982 +$717 +32% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $2,792 +$747 +37% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $2,792 +$747 +37% 31 Dec 2023 10-K 03 Apr 2025 2024 FY
Q3 2023 $2,265 +$221 +11% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $2,265 +$752 +50% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $2,045 +$532 +35% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $2,045 +$602 +42% 31 Dec 2022 10-K 15 Apr 2024 2023 FY
Q3 2022 $2,044 +$706 +53% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $1,513 +$175 +13% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $1,513 +$590 +64% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $1,443 +$520 +56% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $1,338 -$4,478,428 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $1,338 -$3,962,396 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $923 -$3,807,050 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $923 +$305 +49% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 $4,479,766* +$666,638 31 Aug 2020 10-Q 14 Oct 2020 2020 Q2
Q2 2020 $3,963,734* -$123,718 31 May 2020 10-Q 07 Jul 2020 2020 Q1
Q1 2020 $3,807,973* -$617,904 29 Feb 2020 10-Q 14 Jan 2021 2020 Q3
Q4 2019 $618 -$4,731,821 31 Dec 2019 10-K/A 07 May 2021 2020 FY
Q3 2019 $3,813,128* -$1,182,535 31 Aug 2019 10-Q 08 Oct 2019 2019 Q2
Q2 2019 $4,087,452* 31 May 2019 10-Q 03 Jul 2019 2020 Q1
Q1 2019 $4,425,877* 28 Feb 2019 10-K 04 May 2020 2020 FY
Q4 2018 $4,732,439* 30 Nov 2018 10-Q 09 Jan 2019 2019 Q3
Q3 2018 $4,995,663* 31 Aug 2018 10-Q 11 Oct 2018 2019 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.